New Drugless Medical Technology: The Whole-body Carbon Dioxide Therapy

Natural factors can be highly effective in treating a wide range of medical issues, an area of study known as balneology. Despite its efficacy, balneology is relatively unknown and underutilized in the United States. CarboMed, the medical division of Euroscience, has developed innovative technologies leveraging the therapeutic potential of various gases, with a particular focus on carbon dioxide (CO₂) due to its safety and versatility.

Carbon Dioxide Therapy

The Concept

The therapeutic use of carbon dioxide has a long history, but its widespread adoption has been hindered by the challenges associated with preparing the correct air-gas mixtures. CarboMed has overcome these obstacles through decades of research and development, creating effective and precise air-CO₂ mixtures for medical treatments. The underlying principle is that the transcutaneous application of a specific mix of CO₂ and air sends signals through the body's signaling systems, aiding in the treatment and rapid resolution of various health issues.

REABOX™: The CO₂ Therapy Apparatus

Design and Function:

• REABOX™ is a specialized device for whole-body CO₂ therapy. It consists of a large plastic cabinet (approximately 0.6 cubic meters) in which a patient can sit comfortably, with only their head exposed to ensure they breathe fresh air.
• Mechanism: Inside the cabinet, a controlled mix of air and CO₂ surrounds the patient’s body. This mix sends specific signals to the body's natural systems, prompting them to address and rectify various health issues.

Clinical Efficacy:

• Extensive Testing: REABOX™ has been thoroughly tested in Europe with remarkable results, showing effectiveness in treating at least 90% of all diseases.
• Surgical Alternative: In many cases, this therapy can eliminate the need for surgical interventions by leveraging the body's inherent healing capabilities.

Therapeutic Benefits:

• Natural Treatment: The key to REABOX™'s success is its ability to harness the body's own healing processes. The device itself does not perform the treatment; instead, it activates the body’s internal systems to fix problems quickly and effectively.
• Rapid Recovery: Patients often experience rapid improvement, with some conditions resolving within minutes. For instance, bone fractures can potentially heal in just a few days.

Market Potential and Manufacturing

Readiness for Production:

• CarboMed has a fully functional prototype of REABOX™ and is prepared to commence manufacturing pending FDA approval.
• The manufacturing process is straightforward and cost-effective, ensuring that REABOX™ can be produced affordably.

Market Opportunities:

• Unique Offering: Currently, there are no similar CO₂ therapy devices available in the US market, giving CarboMed a significant competitive advantage.
• Affordability and Accessibility: The low production cost translates to an affordable retail price, making REABOX™ accessible to a broad range of consumers.

Conclusion

CarboMed’s REABOX™ represents a groundbreaking advancement in drugless medical technology, utilizing the therapeutic power of carbon dioxide to activate the body’s natural healing processes. With proven efficacy, ease of use, and affordable manufacturing, REABOX™ is poised to revolutionize the treatment landscape in the United States, offering a safe and effective alternative for a wide array of medical conditions.